• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Enabling Statisticians to Lead through Innovation and Excellence

    Enabling Statisticians to Lead through Innovation and Excellence

Search The Effective Statistician

  • Winning with Words and Graphs: The Effective Statistician presentation and data visualization masterclass
  • How to be an effective statistician
  • Start here!
  • Podcast
    • PSI Careers
  • Free resources on visualization
    • Recording available: Flatten the curve – learnings from COVID-19 visualizations to better explore and communicate your data
  • Free resources on influencing
    • The Effective Statistician Leadership Program
    • Recording available: It’s not enough to be right!
  • Join The Effective Statistician LinkedIn group
  • Quick tips to be more effective
  • Legal disclosure – about us
    • Datenschutzerklärung – sorry, still in German…
You are here: Home / Innovation / Subgroup identification using SIDES and its practical challenges

Subgroup identification using SIDES and its practical challenges

By Alexander on 2019-05-14 0

Subgroup identification using SIDES and its practical challenges
  • share 
  • tweet  
  • share  
  • share 
  • save  

Interview with Andy Nicholls

One of the most common questions I got asked during my nearly 2 decades of being a statistician sounds similar to this: “Which patients have the best response to treatment?”

I’m sure, we all face this situation sooner or later and not surprisingly lots of research has happened in the last years on this area. In todays episode, we will help you to understand one of the best approaches I have come across to solve this problem in a rigorous yet sophisticated way: the SIDES approach.

Both Andy Nicholls and I have applied this approach in the past and we’ll use an example, which he presented during a PSI webinar.

Listen to this episode to learn step by step how to apply the SIDES method.

Abstract of the related PSI webinar presentation

Using the SIDES algorithm to the identify patient phenotypes that have the potential to benefit most from switching to Relvar

In 2016 GSK successfully completed the Salford Lung Study, a 12-month, open label, randomised, effectiveness study to evaluate fluticasone furoate (FF, GW685698)/vilanterol (VI, GW642444) Inhalation Powder delivered once daily via a Novel Dry Powder Inhaler (NDPI) compared with the existing COPD maintenance therapy alone in subjects with Chronic Obstructive Pulmonary Disease (COPD).  Upon completion of the study, the Scientific Committee expressed an interest in using a data-driven approach in order to identify patient subgroups for which the treatment effect was strongest. In this presentation we will look at why SIDES was chosen for this analysis, the design parameters, and how it fared.

About Andy Nicholls

Andy is a Statistician with a strong interest in Data Science, having previously worked as a specialist R Consultant and Data Scientist for Mango Solutions.  On re-joining GSK in 2017, Andy provided support to the Relvar project, for which he led an exploratory cluster analysis using Salford Lung Study data in order to try to identify patient subgroups that might experience an additional real-world benefit of Relvar.  He now works in GSK’s new Statistical Data Sciences division within BioStats and is Business Systems Owner for the BioStats HPC environment for R.

Never miss an episode of The Effective Statistician

Join hundreds of your peers and subscribe to get our latest updates by email!

Get the shownotes of our podcast episodes plus tips and tricks to increase your impact at work to boost your career!

Success! Now check your email to confirm your subscription.

There was an error submitting your subscription. Please try again.

We won't send you spam. Unsubscribe at any time. Powered by ConvertKit
  • share 
  • tweet  
  • share  
  • share 
  • save  

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Primary Sidebar

Join the PSI newsletter here!

Categories

  • Excellence
  • Innovation
  • Knowledge
  • Leadership
  • PSI Calc Podcast

Recent Posts

  • Extrapolation to paedriatics
  • How to integrate external data into your clinical studies: from theory to application
  • A preview into the PSI conference
  • Patient-reported outcomes and the FDA Patient-Focused Drug Development Guidance
  • Apps on prescription paid by the government

Archives

  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018

The podcast is run in association with PSI

Copyright © 2022 · Smart Passive Income Pro on Genesis Framework · WordPress · Log in